Meeting
2022 ASCO Quality Care Symposium
Hepatitis B screening to reduce the risk of viral reactivation in gynecologic oncology patients receiving chemotherapy at a regional tertiary cancer center: A quality improvement initiative.
Authors
Sarah J. Mah
McMaster University and Juravinski Cancer Centre, Hamilton, ON, Canada
Sarah J. Mah, Jonathan Bellini, Lucy Zhao, Julie My Van Nguyen, Clare Reade, Waldo Jimenez, Vanessa Carlson, Nidhi J. Kumar Tyagi, Laurence Bernard, Gregory Russell Pond, Lua Ruhiyyih Eiriksson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Palliative and Supportive Care,Technology and Innovation in Quality of Care,Quality, Safety, and Implementation Science
Sub Track
Quality Improvement Research and Implementation Science
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 332)
DOI
10.1200/JCO.2022.40.28_suppl.332
Abstract #
332
Poster Bd #
D5
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Changing the electronic health record to optimize pre-chemotherapy lab orders.
First Author: Barbara Lam
Poster
2019 ASCO Quality Care Symposium
Preventing complications: Hepatitis B screening in cancer patients undergoing systemic therapy.
First Author: Rebecca M. Prince
First Author: Ivy Abraham
Poster
2018 ASCO Quality Care Symposium
Implementation of a hepatitis B screening process prior to CD20 therapy treatment in an oncology practice.
First Author: Ali McBride